By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for ETF Amplify Weight Loss Drug & Treatment ETF

Amplify Weight Loss Drug & Treatment ETF (THNR)

AMEX Currency in USD
$396.00
-$5.88
-1.46%
Last Update: 18 Jul 2026, 10:12
$5.18m
Assets Under Management
59.00%
Expense Ratio
0.10%
Forward Dividend Yield
$277.97-$498.35
52 Week Range

THNR Price Chart

Explore Amplify Weight Loss Drug & Treatment ETF interactive price chart. Choose custom timeframes to analyze THNR price movements and trends.

THNR ETF Profile

Key details and information about Amplify Weight Loss Drug & Treatment ETF (THNR).

Sector Focus

Financial Services

Industry

Asset Management

Inception Date

21 May 2024

Country

US

Description

The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.

THNR ETF Performance

View THNR with an interactive analytics dashboard featuring price and candlestick charts, key metrics, holdings breakdowns, and dividend yield history. Open the template in Insights to customize and save it.

Explore Related ETFs

Discover other exchange-traded funds. Select a symbol to access its full profile.

Discover More
Command Palette
Search for a command to run